Ameritas Investment Partners’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-198
Closed -$5.21K – 3242
2026
Q1
$5.21K Hold
198
– – ﹤0.01% 2987
2025
Q4
$49.2K Hold
198
– – ﹤0.01% 2128
2025
Q3
$41.7K Sell
198
-44
-18% -$7.76K ﹤0.01% 2277
2025
Q2
$23.9K Buy
+242
New +$21.1K ﹤0.01% 2579
2023
Q2
– Sell
-55
Closed -$5.52K – 3148
2023
Q1
$5.52K Hold
55
– – ﹤0.01% 2842
2022
Q4
$9.2K Hold
55
– – ﹤0.01% 2830
2022
Q3
$52K Hold
55
– – ﹤0.01% 1946
2022
Q2
$36K Hold
55
– – ﹤0.01% 2205
2022
Q1
$38K Hold
55
– – ﹤0.01% 2221
2021
Q4
$50K Hold
55
– – ﹤0.01% 2130
2021
Q3
$55K Hold
55
– – ﹤0.01% 2088
2021
Q2
$36K Hold
55
– – ﹤0.01% 2401
2021
Q1
$41K Hold
55
– – ﹤0.01% 2200
2020
Q4
$42K Hold
55
– – ﹤0.01% 2081
2020
Q3
$54K Hold
55
– – ﹤0.01% 1783
2020
Q2
$57K Buy
55
+10
+22% +$10.1K ﹤0.01% 1749
2020
Q1
$36K Hold
45
– – ﹤0.01% 1846
2019
Q4
$56K Hold
45
– – ﹤0.01% 1850
2019
Q3
$60K Buy
45
+23
+105% +$36.6K ﹤0.01% 1778
2019
Q2
$38K Buy
22
+11
+100% +$16.8K ﹤0.01% 2067
2019
Q1
$20K Buy
+11
New +$18.4K ﹤0.01% 2374

Other funds holding GOSS

Ameritas Investment Partners's GOSS Position: Q2 2026 in Review

Ameritas Investment Partners sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 198 shares — an estimated $5.21K sold.

Ameritas Investment Partners first reported a position in GOSS in Q1 2019 and held it in 21 quarters. The position peaked at $60K in Q3 2019. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Ameritas Investment Partners reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Ameritas Investment Partners sold 198 Gossamer Bio shares in Q2 2026, an estimated $5.21K.
  • Ameritas Investment Partners first reported a position in Gossamer Bio in Q1 2019 and held it in 21 quarters.
  • Ameritas Investment Partners's Gossamer Bio position peaked at $60K in Q3 2019.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.